Soung, J., Tiu, L., Veverka, K., & Hong, C.-H. (2018). Patient Preference for Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam or Topical Suspension vs. Latest Topical Treatment in the PSO-INSIGHTFUL Study. SKIN The Journal of Cutaneous Medicine, 2(S1), S10. https://doi.org/10.25251/skin.2.supp.10